Massachusetts Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Healthcare Journal.

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Press releases published on January 13, 2026

January 13, 2026

Boehringer Ingelheim advances potential first-in-class IL-11 inhibitor to Phase II Clinical Research in Idiopathic Pulmonary Fibrosis

GlobeNewswire

January 13, 2026

Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights

GlobeNewswire

January 13, 2026

Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue

GlobeNewswire

January 13, 2026

Pasithea Therapeutics Provides Outlook on PAS-004 Clinical Programs and Data Release Timelines

GlobeNewswire

January 13, 2026

Kymera Therapeutics Outlines Key 2026 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs

GlobeNewswire

January 13, 2026

Ocugen to Host Webcast on Thursday, January 15 at 8:30 a.m. ET to Discuss OCU410 Phase 2 Clinical Trial Data

GlobeNewswire

January 13, 2026

Traws Pharma Files Tivoxavir Marboxil Investigational New Drug (IND) Application for Influenza Therapy, and Provides Updated Results from the Ongoing Clinical Study of Ratutrelvir in PAXLOVID®-Eligible and Ineligible COVID-19 Patients

GlobeNewswire

January 13, 2026

SciSparc Signs Definitive Agreement to Acquire a Treasury of Patents for the Endoscope Market- Entering Multi-Billion Dollar Opportunity

GlobeNewswire

January 13, 2026

Aktis Oncology Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire

January 13, 2026

Kestra Medical Technologies Announces Strategic Collaboration with Biobeat Technologies to Expand Diagnostic Insight for Wearable Defibrillator Patients During Cardiac Recovery

GlobeNewswire

January 13, 2026

Aclarion Strengthens Balance Sheet and Extends Cash Runway Into 2028

GlobeNewswire

January 13, 2026

Bio Usawa Receives Ghana FDA Approval for BioUcenta™

GlobeNewswire

January 13, 2026

Nxera Pharma to Receive US$3.6 Million in Milestone Payment Pursuant to Research Collaboration with Centessa

GlobeNewswire

January 13, 2026

Basilea geht Partnerschaft mit INCATE ein, um Innovationen im Bereich Antipilzmittel zu unterstützen

GlobeNewswire

January 13, 2026

Basilea joins INCATE to support antifungal innovation

GlobeNewswire

January 13, 2026

argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART in AChR-Ab Seronegative gMG

GlobeNewswire

January 13, 2026

Kuros Biosciences to provide investor update at Octavian and Baader Bank Conferences

GlobeNewswire

January 13, 2026

Metabo Drops 2026: Is It Legit? Ingredients, Safety Facts, and Consumer Analysis

GlobeNewswire

January 13, 2026

Wegovy Pill vs Wegovy Shot: Oral vs Injectable Semaglutide Differences — 2026 FDA Launch Analysis via Ro.co

GlobeNewswire

January 13, 2026

Best Hair Regrowth Formula 2026 (BioGrow RX): Consumer Report Compares Biotin Supplements to Topical Treatments

GlobeNewswire